Evaluation of anxiety and depression in patients with morphea taking immunosuppressive drugs during the COVID-19 pandemic.
Mohammad Shahidi DadrasZohreh AhmadzadehShima YounespourFahimeh AbdollahimajdPublished in: The Journal of dermatological treatment (2020)
Although there was no significant difference in anxiety and depression between the groups, it is recommended to provide psychiatric counseling opportunities to morphea patients to improve treatment outcomes during this pandemic.